Source - RNS
RNS Number : 0895H
Arix Bioscience Plc
05 June 2017
 

05 June 2017 

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

 

 

LONDON, 05 June 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, announces that several key members of its leadership team have purchased shares in the Company.

 

Joe Anderson, Chief Executive Officer of Arix Bioscience, purchased 55,000 ordinary shares in the Company at a price of 206.10p per Ordinary Share.

 

James Rawlingson, Chief Financial Officer of Arix Bioscience, purchased 26,000 ordinary shares in the Company at a price of 206.10p per Ordinary Share. 

 

Jon Peacock, Chairman of Arix Bioscience, purchased 28,016 ordinary shares in the Company at a price of 206.10p per Ordinary Share.

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joseph Anderson

2

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

 Purchase of Ordinary Shares 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.10 pence

55,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

 02 June 2017 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Hedley Rawlingson

2

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

 Purchase of Ordinary Shares 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.10 pence

26,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

 02 June 2017 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonathan Peacock

2

Reason for the notification

a)

Position / status

Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

 Purchase of Ordinary Shares 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.10 pence

28,016

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

 02 June 2017 

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information:

 

James Rawlingson                           Chief Financial Officer                +44 (0)207 290 1050

 

 

 - Ends -

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFZLLBDQFEBBB